Demo Sign up Log In

Intellia Therapeutics Inc (NTLA)

Cash Conversion Ratio

0.80×

Quarterly · Period ending: Jun 30, 2026

NTLA Cash Conversion Ratio

Latest reported0.80×period endingJun 30, 2026

Latest reported0.80×period endingJun 30, 2026

NTLA Quarterly Cash Conversion Ratio (-3.94× → 0.80×)

Latest values, visible window

High-resolution chart · PNG

NTLA cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.7964×
Mar 31, 2026	1.2202×
Dec 31, 2025	0.7246×
Sep 30, 2025	0.7592×
Jun 30, 2025	0.9862×
Mar 31, 2025	1.3091×
Dec 31, 2024	0.6686×
Sep 30, 2024	0.6345×
Jun 30, 2024	0.4028×
Mar 31, 2024	1.1464×
Dec 31, 2023	0.7156×
Sep 30, 2023	0.8649×
Jun 30, 2023	0.7651×
Mar 31, 2023	1.0973×
Dec 31, 2022	0.8269×
Sep 30, 2022	0.7309×
Jun 30, 2022	0.8847×
Mar 31, 2022	0.8583×
Dec 31, 2021	0.708×
Sep 30, 2021	0.9709×
Jun 30, 2021	0.8127×
Mar 31, 2021	1.1858×
Dec 31, 2020	0.9772×
Sep 30, 2020	1.0509×
Jun 30, 2020	-1.7405×
Mar 31, 2020	1.2384×
Dec 31, 2019	1.1046×
Sep 30, 2019	1.1507×
Jun 30, 2019	1.1143×
Mar 31, 2019	1.0477×
Dec 31, 2018	0.5313×
Sep 30, 2018	0.6374×
Jun 30, 2018	1.0529×
Mar 31, 2018	0.9187×
Dec 31, 2017	0.9891×
Sep 30, 2017	1.2473×
Jun 30, 2017	1.087×
Mar 31, 2017	1.2319×
Dec 31, 2016	1.6865×
Sep 30, 2016	1.098×
Jun 30, 2016	-9.6236×
Mar 31, 2016	1.5591×
Dec 31, 2015	1.2088×
Sep 30, 2015	1.2816×
Jun 30, 2015	-0.5217×
Mar 31, 2015	-3.9396×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.